A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...

Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...

A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and a decline in mental ...

From color-changing skin to jet-propelled motion, squid and cuttlefish have long fascinated scientists. To understand the origins of their unique characteristics, many attempts have been made to ...

Glucocorticoid-induced osteoporosis (GIOP) remains a major clinical challenge, affecting up to half of patients receiving long-term glucocorticoid therapy. Excessive oxidative stress and impaired ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for ...

Mostajo-Radji is a researcher at the UC Santa Cruz Genomics Institute and a member of the Braingeneers group. The campus will ...

A single-atom nanozyme mimicking cytochrome c oxidase restores mitochondrial energy production in stem cells, shifting their ...

Background: Exercise unmasks limitations in multi-organ system reserve capacity characteristic of heart failure with preserved ejection fraction (HFpEF). However, the metabolic and genetic ...

Researchers from the Paris Brain Institute and Sainte-Justine University Hospital in Montreal have, for the first time, ...